Items Tagged ‘EGFR-positive’

September 22nd, 2015

Gilotrif Improves Outcomes in Lung Cancer


The targeted agent Gilotrif (afatinib) improves outcomes compared to Tarceva (erlotinib) among patients with squamous cell lung cancer. These results were recently published in The Lancet Oncology. Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, NSCLC accounts for 75–80% of all lung cancers. Although progress has been made in […]

View full entry

Tags: afatinib, EGFR-positive, General Lung Cancer, gilotrif, Lung Cancer, News, squamous cell lung cancer, targeted agent